Document Detail

Adherence to Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia: A Brazilian Single-Center Cohort.
MedLine Citation:
PMID:  23363706     Owner:  NLM     Status:  Publisher    
The introduction of oral tyrosine kinase inhibitors (TKIs) has dramatically improved outcomes in chronic myeloid leukemia (CML) patients. However, treatment success is directly related to good long-term adherence. Adherence to TKI therapy was evaluated in 137 CML patients over a period of 1 year. Three different methods were used to evaluate adherence: the Morisky questionnaire, a medication diary and the medication possession ratio (MPR). MPR was the most effective method of assessing adherence (median adherence 96.5%; p = 0.0001), duration of TKI treatment was the variable that most impacted adherence (p = 0.03), and the MPR was inversely correlated to the duration of therapy. Additionally, participation in clinical trials, better quality of life as reported by patients and higher socioeconomic status were all related to better compliance (p = 0.02, 0.007 and 0.01, respectively). For patients treated with imatinib for 24-48 months (n = 22), individuals with major molecular response (MMR) had a significantly better MPR than those who failed to achieve MMR (p = 0.04). In this group, the mean MPR was 87% for the population without apparent molecular response and 96% for those achieving MMR; however, only 24% of the patients were completely adherent to TKI treatment.
Maria H de Almeida; Katia B B Pagnano; Afonso C Vigorito; Irene Lorand-Metze; Carmino A de Souza
Related Documents :
16890856 - Compromised bypass graft outcomes after minimal-incision vein harvest.
23195006 - High incidence of rejection episodes and poor tolerance of sirolimus in a protocol with...
23726576 - Comparison of clinical outcomes in hepatitis b virus-positive kidney transplant recipie...
22993646 - Long-term effects of the "heidelberg model of music therapy" in patients with chronic t...
25207296 - Clinical outcome of femoral osteotomy in patients with legg-calve´-perthes disease.
21486416 - Long-term efficacy and safety of self-intracavernous injection of prostaglandin e1 for ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-25
Journal Detail:
Title:  Acta haematologica     Volume:  130     ISSN:  1421-9662     ISO Abbreviation:  Acta Haematol.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-31     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0141053     Medline TA:  Acta Haematol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  16-22     Citation Subset:  -    
Copyright Information:
Copyright © 2013 S. Karger AG, Basel.
Hematology and Hemotherapy Center, University of Campinas, Campinas, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Comparative analysis of tandem repeats from hundreds of species reveals unique insights into centrom...
Next Document:  Adiponectin in eutrophic and obese children as a biomarker to predict metabolic syndrome and each of...